Evaluation of the Pharmacokinetic Drug-drug Interactions Between VX-993 and Metformin in Healthy Adults
Clinical trial NCT06523595 · COMPLETED
Trial details
- NCT number
- NCT06523595
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2024-12-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.